Inventiva (IVA) Long-Term Debt Issuances (2022 - 2024)
Inventiva (IVA) posted quarterly Long-Term Debt Issuances of $14.0 million for Q4 2024, down 0.77% quarter-over-quarter from $14.1 million in Q2 2024.
Inventiva (IVA) Long-Term Debt Issuances (2022 - 2024) Analysis & Trends
Inventiva's Long-Term Debt Issuances history runs 2 years deep, the most recent figure standing at $14.0 million for Q4 2024.
- In Q4 2024, Long-Term Debt Issuances changed N/A year-over-year to $14.0 million; the TTM figure through Dec 2024 stood at $14.0 million (changed N/A YoY), while the FY2024 annual figure was $26.6 million, changed N/A from the prior year.
- Long-Term Debt Issuances for Q4 2024 stood at $14.0 million, down from $14.1 million in the prior quarter.
- The five-year high for Long-Term Debt Issuances was $14.1 million in Q2 2024, with the low at $5.4 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -675,522.58 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Inventiva | 888.89 Mn | 888.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 14.00 Mn |
| Dec 31, 2024 | 14.00 Mn |
| Jun 30, 2024 | 14.11 Mn |
| Jun 30, 2024 | 14.11 Mn |
| Dec 31, 2022 | 5.45 Mn |
| Dec 31, 2022 | 5.45 Mn |
| Sep 22, 2022 | 5.57 Mn |
| Sep 22, 2022 | 5.57 Mn |